Hadron Therapy - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Table of Contents

 1 Market Overview
    1.1 Hadron Therapy Product Introduction
    1.2 Global Hadron Therapy Market Size Forecast
    1.3 Hadron Therapy Market Trends & Drivers
        1.3.1 Hadron Therapy Industry Trends
        1.3.2 Hadron Therapy Market Drivers & Opportunity
        1.3.3 Hadron Therapy Market Challenges
        1.3.4 Hadron Therapy Market Restraints
    1.4 Assumptions and Limitations
    1.5 Study Objectives
    1.6 Years Considered

 2 Competitive Analysis by Company
    2.1 Global Hadron Therapy Players Revenue Ranking (2023)
    2.2 Global Hadron Therapy Revenue by Company (2019-2024)
    2.3 Key Companies Hadron Therapy Manufacturing Base Distribution and Headquarters
    2.4 Key Companies Hadron Therapy Product Offered
    2.5 Key Companies Time to Begin Mass Production of Hadron Therapy
    2.6 Hadron Therapy Market Competitive Analysis
        2.6.1 Hadron Therapy Market Concentration Rate (2019-2024)
        2.6.2 Global 5 and 10 Largest Companies by Hadron Therapy Revenue in 2023
        2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hadron Therapy as of 2023)
    2.7 Mergers & Acquisitions, Expansion

 3 Segmentation by Type
    3.1 Introduction by Type
        3.1.1 Electron Beam
        3.1.2 Proton Beam
        3.1.3 Neutron Beam
        3.1.4 Carbon Ion Beam
        3.1.5 Alpha Particle Beam
        3.1.6 Beta Particle Beam
    3.2 Global Hadron Therapy Sales Value by Type
        3.2.1 Global Hadron Therapy Sales Value by Type (2019 VS 2023 VS 2030)
        3.2.2 Global Hadron Therapy Sales Value, by Type (2019-2030)
        3.2.3 Global Hadron Therapy Sales Value, by Type (%) (2019-2030)

 4 Segmentation by Application
    4.1 Introduction by Application
        4.1.1 Pediatric Cancer
        4.1.2 Bone and Soft Tissue Cancer
        4.1.3 Prostate Cancer
        4.1.4 Lung Cancer
        4.1.5 Liver Cancer
        4.1.6 Eye Cancer
        4.1.7 Head & Neck Cancer
        4.1.8 Others Applications (Renal Cell Carcinoma, Cervical, Gastric, and Lymphoma)
    4.2 Global Hadron Therapy Sales Value by Application
        4.2.1 Global Hadron Therapy Sales Value by Application (2019 VS 2023 VS 2030)
        4.2.2 Global Hadron Therapy Sales Value, by Application (2019-2030)
        4.2.3 Global Hadron Therapy Sales Value, by Application (%) (2019-2030)

 5 Segmentation by Region
    5.1 Global Hadron Therapy Sales Value by Region
        5.1.1 Global Hadron Therapy Sales Value by Region: 2019 VS 2023 VS 2030
        5.1.2 Global Hadron Therapy Sales Value by Region (2019-2024)
        5.1.3 Global Hadron Therapy Sales Value by Region (2025-2030)
        5.1.4 Global Hadron Therapy Sales Value by Region (%), (2019-2030)
    5.2 North America
        5.2.1 North America Hadron Therapy Sales Value, 2019-2030
        5.2.2 North America Hadron Therapy Sales Value by Country (%), 2023 VS 2030
    5.3 Europe
        5.3.1 Europe Hadron Therapy Sales Value, 2019-2030
        5.3.2 Europe Hadron Therapy Sales Value by Country (%), 2023 VS 2030
    5.4 Asia Pacific
        5.4.1 Asia Pacific Hadron Therapy Sales Value, 2019-2030
        5.4.2 Asia Pacific Hadron Therapy Sales Value by Country (%), 2023 VS 2030
    5.5 South America
        5.5.1 South America Hadron Therapy Sales Value, 2019-2030
        5.5.2 South America Hadron Therapy Sales Value by Country (%), 2023 VS 2030
    5.6 Middle East & Africa
        5.6.1 Middle East & Africa Hadron Therapy Sales Value, 2019-2030
        5.6.2 Middle East & Africa Hadron Therapy Sales Value by Country (%), 2023 VS 2030

 6 Segmentation by Key Countries/Regions
    6.1 Key Countries/Regions Hadron Therapy Sales Value Growth Trends, 2019 VS 2023 VS 2030
    6.2 Key Countries/Regions Hadron Therapy Sales Value
    6.3 United States
        6.3.1 United States Hadron Therapy Sales Value, 2019-2030
        6.3.2 United States Hadron Therapy Sales Value by Type (%), 2023 VS 2030
        6.3.3 United States Hadron Therapy Sales Value by Application, 2023 VS 2030
    6.4 Europe
        6.4.1 Europe Hadron Therapy Sales Value, 2019-2030
        6.4.2 Europe Hadron Therapy Sales Value by Type (%), 2023 VS 2030
        6.4.3 Europe Hadron Therapy Sales Value by Application, 2023 VS 2030
    6.5 China
        6.5.1 China Hadron Therapy Sales Value, 2019-2030
        6.5.2 China Hadron Therapy Sales Value by Type (%), 2023 VS 2030
        6.5.3 China Hadron Therapy Sales Value by Application, 2023 VS 2030
    6.6 Japan
        6.6.1 Japan Hadron Therapy Sales Value, 2019-2030
        6.6.2 Japan Hadron Therapy Sales Value by Type (%), 2023 VS 2030
        6.6.3 Japan Hadron Therapy Sales Value by Application, 2023 VS 2030
    6.7 South Korea
        6.7.1 South Korea Hadron Therapy Sales Value, 2019-2030
        6.7.2 South Korea Hadron Therapy Sales Value by Type (%), 2023 VS 2030
        6.7.3 South Korea Hadron Therapy Sales Value by Application, 2023 VS 2030
    6.8 Southeast Asia
        6.8.1 Southeast Asia Hadron Therapy Sales Value, 2019-2030
        6.8.2 Southeast Asia Hadron Therapy Sales Value by Type (%), 2023 VS 2030
        6.8.3 Southeast Asia Hadron Therapy Sales Value by Application, 2023 VS 2030
    6.9 India
        6.9.1 India Hadron Therapy Sales Value, 2019-2030
        6.9.2 India Hadron Therapy Sales Value by Type (%), 2023 VS 2030
        6.9.3 India Hadron Therapy Sales Value by Application, 2023 VS 2030

 7 Company Profiles
    7.1 Koninklijke Philips
        7.1.1 Koninklijke Philips Profile
        7.1.2 Koninklijke Philips Main Business
        7.1.3 Koninklijke Philips Hadron Therapy Products, Services and Solutions
        7.1.4 Koninklijke Philips Hadron Therapy Revenue (US$ Million) & (2019-2024)
        7.1.5 Koninklijke Philips Recent Developments
    7.2 Advanced Oncotherapy
        7.2.1 Advanced Oncotherapy Profile
        7.2.2 Advanced Oncotherapy Main Business
        7.2.3 Advanced Oncotherapy Hadron Therapy Products, Services and Solutions
        7.2.4 Advanced Oncotherapy Hadron Therapy Revenue (US$ Million) & (2019-2024)
        7.2.5 Advanced Oncotherapy Recent Developments
    7.3 Varian Medical Systems
        7.3.1 Varian Medical Systems Profile
        7.3.2 Varian Medical Systems Main Business
        7.3.3 Varian Medical Systems Hadron Therapy Products, Services and Solutions
        7.3.4 Varian Medical Systems Hadron Therapy Revenue (US$ Million) & (2019-2024)
        7.3.5 Optivus Proton Therapy Recent Developments
    7.4 Optivus Proton Therapy
        7.4.1 Optivus Proton Therapy Profile
        7.4.2 Optivus Proton Therapy Main Business
        7.4.3 Optivus Proton Therapy Hadron Therapy Products, Services and Solutions
        7.4.4 Optivus Proton Therapy Hadron Therapy Revenue (US$ Million) & (2019-2024)
        7.4.5 Optivus Proton Therapy Recent Developments
    7.5 Hitachi
        7.5.1 Hitachi Profile
        7.5.2 Hitachi Main Business
        7.5.3 Hitachi Hadron Therapy Products, Services and Solutions
        7.5.4 Hitachi Hadron Therapy Revenue (US$ Million) & (2019-2024)
        7.5.5 Hitachi Recent Developments
    7.6 Mevion Medical Systems
        7.6.1 Mevion Medical Systems Profile
        7.6.2 Mevion Medical Systems Main Business
        7.6.3 Mevion Medical Systems Hadron Therapy Products, Services and Solutions
        7.6.4 Mevion Medical Systems Hadron Therapy Revenue (US$ Million) & (2019-2024)
        7.6.5 Mevion Medical Systems Recent Developments
    7.7 ProTom International
        7.7.1 ProTom International Profile
        7.7.2 ProTom International Main Business
        7.7.3 ProTom International Hadron Therapy Products, Services and Solutions
        7.7.4 ProTom International Hadron Therapy Revenue (US$ Million) & (2019-2024)
        7.7.5 ProTom International Recent Developments
    7.8 Mitsubishi Electric
        7.8.1 Mitsubishi Electric Profile
        7.8.2 Mitsubishi Electric Main Business
        7.8.3 Mitsubishi Electric Hadron Therapy Products, Services and Solutions
        7.8.4 Mitsubishi Electric Hadron Therapy Revenue (US$ Million) & (2019-2024)
        7.8.5 Mitsubishi Electric Recent Developments
    7.9 Sumitomo
        7.9.1 Sumitomo Profile
        7.9.2 Sumitomo Main Business
        7.9.3 Sumitomo Hadron Therapy Products, Services and Solutions
        7.9.4 Sumitomo Hadron Therapy Revenue (US$ Million) & (2019-2024)
        7.9.5 Sumitomo Recent Developments
    7.10 ProNova Solutions
        7.10.1 ProNova Solutions Profile
        7.10.2 ProNova Solutions Main Business
        7.10.3 ProNova Solutions Hadron Therapy Products, Services and Solutions
        7.10.4 ProNova Solutions Hadron Therapy Revenue (US$ Million) & (2019-2024)
        7.10.5 ProNova Solutions Recent Developments

 8 Industry Chain Analysis
    8.1 Hadron Therapy Industrial Chain
    8.2 Hadron Therapy Upstream Analysis
        8.2.1 Key Raw Materials
        8.2.2 Raw Materials Key Suppliers
        8.2.3 Manufacturing Cost Structure
    8.3 Midstream Analysis
    8.4 Downstream Analysis (Customers Analysis)
    8.5 Sales Model and Sales Channels
        8.5.1 Hadron Therapy Sales Model
        8.5.2 Sales Channel
        8.5.3 Hadron Therapy Distributors

 9 Research Findings and Conclusion

 10 Appendix
    10.1 Research Methodology
        10.1.1 Methodology/Research Approach
        10.1.2 Data Source
    10.2 Author Details
    10.3 Disclaimer

Table of Figures

List of Tables
    Table 1. Hadron Therapy Market Trends
    Table 2. Hadron Therapy Market Drivers & Opportunity
    Table 3. Hadron Therapy Market Challenges
    Table 4. Hadron Therapy Market Restraints
    Table 5. Global Hadron Therapy Revenue by Company (2019-2024) & (US$ Million)
    Table 6. Global Hadron Therapy Revenue Market Share by Company (2019-2024)
    Table 7. Key Companies Hadron Therapy Manufacturing Base Distribution and Headquarters
    Table 8. Key Companies Hadron Therapy Product Type
    Table 9. Key Companies Time to Begin Mass Production of Hadron Therapy
    Table 10. Global Hadron Therapy Companies Market Concentration Ratio (CR5 and HHI)
    Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hadron Therapy as of 2023)
    Table 12. Mergers & Acquisitions, Expansion Plans
    Table 13. Global Hadron Therapy Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
    Table 14. Global Hadron Therapy Sales Value by Type (2019-2024) & (US$ Million)
    Table 15. Global Hadron Therapy Sales Value by Type (2025-2030) & (US$ Million)
    Table 16. Global Hadron Therapy Sales Market Share in Value by Type (2019-2024) & (%)
    Table 17. Global Hadron Therapy Sales Market Share in Value by Type (2025-2030) & (%)
    Table 18. Global Hadron Therapy Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
    Table 19. Global Hadron Therapy Sales Value by Application (2019-2024) & (US$ Million)
    Table 20. Global Hadron Therapy Sales Value by Application (2025-2030) & (US$ Million)
    Table 21. Global Hadron Therapy Sales Market Share in Value by Application (2019-2024) & (%)
    Table 22. Global Hadron Therapy Sales Market Share in Value by Application (2025-2030) & (%)
    Table 23. Global Hadron Therapy Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 24. Global Hadron Therapy Sales Value by Region (2019-2024) & (US$ Million)
    Table 25. Global Hadron Therapy Sales Value by Region (2025-2030) & (US$ Million)
    Table 26. Global Hadron Therapy Sales Value by Region (2019-2024) & (%)
    Table 27. Global Hadron Therapy Sales Value by Region (2025-2030) & (%)
    Table 28. Key Countries/Regions Hadron Therapy Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
    Table 29. Key Countries/Regions Hadron Therapy Sales Value, (2019-2024) & (US$ Million)
    Table 30. Key Countries/Regions Hadron Therapy Sales Value, (2025-2030) & (US$ Million)
    Table 31. Koninklijke Philips Basic Information List
    Table 32. Koninklijke Philips Description and Business Overview
    Table 33. Koninklijke Philips Hadron Therapy Products, Services and Solutions
    Table 34. Revenue (US$ Million) in Hadron Therapy Business of Koninklijke Philips (2019-2024)
    Table 35. Koninklijke Philips Recent Developments
    Table 36. Advanced Oncotherapy Basic Information List
    Table 37. Advanced Oncotherapy Description and Business Overview
    Table 38. Advanced Oncotherapy Hadron Therapy Products, Services and Solutions
    Table 39. Revenue (US$ Million) in Hadron Therapy Business of Advanced Oncotherapy (2019-2024)
    Table 40. Advanced Oncotherapy Recent Developments
    Table 41. Varian Medical Systems Basic Information List
    Table 42. Varian Medical Systems Description and Business Overview
    Table 43. Varian Medical Systems Hadron Therapy Products, Services and Solutions
    Table 44. Revenue (US$ Million) in Hadron Therapy Business of Varian Medical Systems (2019-2024)
    Table 45. Varian Medical Systems Recent Developments
    Table 46. Optivus Proton Therapy Basic Information List
    Table 47. Optivus Proton Therapy Description and Business Overview
    Table 48. Optivus Proton Therapy Hadron Therapy Products, Services and Solutions
    Table 49. Revenue (US$ Million) in Hadron Therapy Business of Optivus Proton Therapy (2019-2024)
    Table 50. Optivus Proton Therapy Recent Developments
    Table 51. Hitachi Basic Information List
    Table 52. Hitachi Description and Business Overview
    Table 53. Hitachi Hadron Therapy Products, Services and Solutions
    Table 54. Revenue (US$ Million) in Hadron Therapy Business of Hitachi (2019-2024)
    Table 55. Hitachi Recent Developments
    Table 56. Mevion Medical Systems Basic Information List
    Table 57. Mevion Medical Systems Description and Business Overview
    Table 58. Mevion Medical Systems Hadron Therapy Products, Services and Solutions
    Table 59. Revenue (US$ Million) in Hadron Therapy Business of Mevion Medical Systems (2019-2024)
    Table 60. Mevion Medical Systems Recent Developments
    Table 61. ProTom International Basic Information List
    Table 62. ProTom International Description and Business Overview
    Table 63. ProTom International Hadron Therapy Products, Services and Solutions
    Table 64. Revenue (US$ Million) in Hadron Therapy Business of ProTom International (2019-2024)
    Table 65. ProTom International Recent Developments
    Table 66. Mitsubishi Electric Basic Information List
    Table 67. Mitsubishi Electric Description and Business Overview
    Table 68. Mitsubishi Electric Hadron Therapy Products, Services and Solutions
    Table 69. Revenue (US$ Million) in Hadron Therapy Business of Mitsubishi Electric (2019-2024)
    Table 70. Mitsubishi Electric Recent Developments
    Table 71. Sumitomo Basic Information List
    Table 72. Sumitomo Description and Business Overview
    Table 73. Sumitomo Hadron Therapy Products, Services and Solutions
    Table 74. Revenue (US$ Million) in Hadron Therapy Business of Sumitomo (2019-2024)
    Table 75. Sumitomo Recent Developments
    Table 76. ProNova Solutions Basic Information List
    Table 77. ProNova Solutions Description and Business Overview
    Table 78. ProNova Solutions Hadron Therapy Products, Services and Solutions
    Table 79. Revenue (US$ Million) in Hadron Therapy Business of ProNova Solutions (2019-2024)
    Table 80. ProNova Solutions Recent Developments
    Table 81. Key Raw Materials Lists
    Table 82. Raw Materials Key Suppliers Lists
    Table 83. Hadron Therapy Downstream Customers
    Table 84. Hadron Therapy Distributors List
    Table 85. Research Programs/Design for This Report
    Table 86. Key Data Information from Secondary Sources
    Table 87. Key Data Information from Primary Sources
    Table 88. Business Unit and Senior & Team Lead Analysts
List of Figures
    Figure 1. Hadron Therapy Product Picture
    Figure 2. Global Hadron Therapy Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 3. Global Hadron Therapy Sales Value (2019-2030) & (US$ Million)
    Figure 4. Hadron Therapy Report Years Considered
    Figure 5. Global Hadron Therapy Players Revenue Ranking (2023) & (US$ Million)
    Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Hadron Therapy Revenue in 2023
    Figure 7. Hadron Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
    Figure 8. Electron Beam Picture
    Figure 9. Proton Beam Picture
    Figure 10. Neutron Beam Picture
    Figure 11. Carbon Ion Beam Picture
    Figure 12. Alpha Particle Beam Picture
    Figure 13. Beta Particle Beam Picture
    Figure 14. Global Hadron Therapy Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 15. Global Hadron Therapy Sales Value Market Share by Type, 2023 & 2030
    Figure 16. Product Picture of Pediatric Cancer
    Figure 17. Product Picture of Bone and Soft Tissue Cancer
    Figure 18. Product Picture of Prostate Cancer
    Figure 19. Product Picture of Lung Cancer
    Figure 20. Product Picture of Liver Cancer
    Figure 21. Product Picture of Eye Cancer
    Figure 22. Product Picture of Head & Neck Cancer
    Figure 23. Product Picture of Others Applications (Renal Cell Carcinoma, Cervical, Gastric, and Lymphoma)
    Figure 24. Global Hadron Therapy Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 25. Global Hadron Therapy Sales Value Market Share by Application, 2023 & 2030
    Figure 26. North America Hadron Therapy Sales Value (2019-2030) & (US$ Million)
    Figure 27. North America Hadron Therapy Sales Value by Country (%), 2023 VS 2030
    Figure 28. Europe Hadron Therapy Sales Value (2019-2030) & (US$ Million)
    Figure 29. Europe Hadron Therapy Sales Value by Country (%), 2023 VS 2030
    Figure 30. Asia Pacific Hadron Therapy Sales Value (2019-2030) & (US$ Million)
    Figure 31. Asia Pacific Hadron Therapy Sales Value by Country (%), 2023 VS 2030
    Figure 32. South America Hadron Therapy Sales Value (2019-2030) & (US$ Million)
    Figure 33. South America Hadron Therapy Sales Value by Country (%), 2023 VS 2030
    Figure 34. Middle East & Africa Hadron Therapy Sales Value (2019-2030) & (US$ Million)
    Figure 35. Middle East & Africa Hadron Therapy Sales Value by Country (%), 2023 VS 2030
    Figure 36. Key Countries/Regions Hadron Therapy Sales Value (%), (2019-2030)
    Figure 37. United States Hadron Therapy Sales Value, (2019-2030) & (US$ Million)
    Figure 38. United States Hadron Therapy Sales Value by Type (%), 2023 VS 2030
    Figure 39. United States Hadron Therapy Sales Value by Application (%), 2023 VS 2030
    Figure 40. Europe Hadron Therapy Sales Value, (2019-2030) & (US$ Million)
    Figure 41. Europe Hadron Therapy Sales Value by Type (%), 2023 VS 2030
    Figure 42. Europe Hadron Therapy Sales Value by Application (%), 2023 VS 2030
    Figure 43. China Hadron Therapy Sales Value, (2019-2030) & (US$ Million)
    Figure 44. China Hadron Therapy Sales Value by Type (%), 2023 VS 2030
    Figure 45. China Hadron Therapy Sales Value by Application (%), 2023 VS 2030
    Figure 46. Japan Hadron Therapy Sales Value, (2019-2030) & (US$ Million)
    Figure 47. Japan Hadron Therapy Sales Value by Type (%), 2023 VS 2030
    Figure 48. Japan Hadron Therapy Sales Value by Application (%), 2023 VS 2030
    Figure 49. South Korea Hadron Therapy Sales Value, (2019-2030) & (US$ Million)
    Figure 50. South Korea Hadron Therapy Sales Value by Type (%), 2023 VS 2030
    Figure 51. South Korea Hadron Therapy Sales Value by Application (%), 2023 VS 2030
    Figure 52. Southeast Asia Hadron Therapy Sales Value, (2019-2030) & (US$ Million)
    Figure 53. Southeast Asia Hadron Therapy Sales Value by Type (%), 2023 VS 2030
    Figure 54. Southeast Asia Hadron Therapy Sales Value by Application (%), 2023 VS 2030
    Figure 55. India Hadron Therapy Sales Value, (2019-2030) & (US$ Million)
    Figure 56. India Hadron Therapy Sales Value by Type (%), 2023 VS 2030
    Figure 57. India Hadron Therapy Sales Value by Application (%), 2023 VS 2030
    Figure 58. Hadron Therapy Industrial Chain
    Figure 59. Hadron Therapy Manufacturing Cost Structure
    Figure 60. Channels of Distribution (Direct Sales, and Distribution)
    Figure 61. Bottom-up and Top-down Approaches for This Report
    Figure 62. Data Triangulation